Last reviewed · How we verify
Mintacol (paraoxon)
Mintacol (generic name: paraoxon) is a paraoxon drug. It is currently in unknown development.
Mintacol works by inhibiting the enzyme cholinesterase, which breaks down the neurotransmitter acetylcholine.
Mintacol is a small molecule that acts as a cholinesterase inhibitor. It is used as an ophthalmological drug against glaucoma.
At a glance
| Generic name | paraoxon |
|---|---|
| Drug class | paraoxon |
| Target | Acetylcholinesterase, Carbonic anhydrase 1, Carbonic anhydrase 2 |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Think of acetylcholine like a key that unlocks certain functions in the body. When cholinesterase breaks it down, the key is removed, and those functions are turned off. By stopping cholinesterase from breaking down acetylcholine, Mintacol keeps the key in place, allowing those functions to stay active.
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation (PHASE1)
- Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF (NA)
- Nitric Oxide Bioavailability and Early Life Stress (NO-Stress) (NA)
- Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia (NA)
- Cystic Fibrosis and Endothelial Function: At Rest and During Exercise (PHASE2)
- The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia (PHASE2,PHASE3)
- Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mintacol CI brief — competitive landscape report
- Mintacol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Mintacol
What is Mintacol?
How does Mintacol work?
What is the generic name of Mintacol?
What drug class is Mintacol in?
What development phase is Mintacol in?
What does Mintacol target?
Related
- Drug class: All paraoxon drugs
- Target: All drugs targeting Acetylcholinesterase, Carbonic anhydrase 1, Carbonic anhydrase 2
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing